Unknown

Dataset Information

0

Interspecies recombination, not de novo mutation, maintains virulence after β-lactam resistance acquisition in Streptococcus pneumoniae.


ABSTRACT: As opposed to de novo mutation, β-lactam resistance in S. pneumoniae is often conferred via homologous recombination during horizontal gene transfer. We hypothesize that β-lactam resistance in pathogenic streptococci is restricted to naturally competent species via intra-/interspecies recombination due to in vivo fitness trade-offs of de novo penicillin-binding protein (PBP) mutations. We show that de novo mutant populations have abrogated invasive disease capacity and are difficult to evolve in vivo. Conversely, serially transformed recombinant strains efficiently integrate resistant oral streptococcal DNA, gain penicillin resistance and tolerance, and retain virulence in mice. Large-scale changes in pbp2X, pbp2B, and non-PBP-related genes occur in recombinant isolates. Our results indicate that horizontal transfer of β-lactam resistance engenders initially favorable or minimal cost changes in vivo compared with de novo mutation(s), underscoring the importance of recombination in the emergence of β-lactam resistance and suggesting why some pathogenic streptococci lacking innate competence remain universally susceptible.

SUBMITTER: Nishimoto AT 

PROVIDER: S-EPMC9850807 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Interspecies recombination, not de novo mutation, maintains virulence after β-lactam resistance acquisition in Streptococcus pneumoniae.

Nishimoto Andrew T AT   Dao Tina H TH   Jia Qidong Q   Ortiz-Marquez Juan C JC   Echlin Haley H   Vogel Peter P   van Opijnen Tim T   Rosch Jason W JW  

Cell reports 20221201 11


As opposed to de novo mutation, β-lactam resistance in S. pneumoniae is often conferred via homologous recombination during horizontal gene transfer. We hypothesize that β-lactam resistance in pathogenic streptococci is restricted to naturally competent species via intra-/interspecies recombination due to in vivo fitness trade-offs of de novo penicillin-binding protein (PBP) mutations. We show that de novo mutant populations have abrogated invasive disease capacity and are difficult to evolve in  ...[more]

Similar Datasets

| S-EPMC90704 | biostudies-literature
| S-EPMC4745886 | biostudies-literature
| S-EPMC107097 | biostudies-literature
| S-EPMC6328782 | biostudies-literature
| S-EPMC4291406 | biostudies-literature
| S-EPMC3960169 | biostudies-literature
| S-EPMC3248006 | biostudies-literature
| S-EPMC108710 | biostudies-literature
| S-EPMC3395615 | biostudies-literature
| S-EPMC8875335 | biostudies-literature